Ethanol extract of Polygonum cuspidatum inhibits hepatitis B virus in a stable HBV-producing cell line

Antiviral Research

Volumn 66, Issue 1, 2005, Pages 29-34

  Chang, Jung San ^a   Liu, Hong Wen ^a   Wang, Kuo Chih ^b   Chen, Mei Chun ^a   Chiang, Lien Chai ^a   Hua, Yi Cheng ^b   Lin, Chun Ching ^b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Antiviral assay; Chronic B hepatitis; HepG2; Polygonum cuspidatum; Polymerase chain reaction; TaqMan

Indexed keywords

ALCOHOL; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; PLANT EXTRACT; POLYGONUM CUSPIDATUM EXTRACT; UNCLASSIFIED DRUG; WATER;

ANTIGEN DETECTION; ANTIGEN EXPRESSION; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPATITIS B VIRUS; HEPATOBLASTOMA; HUMAN; HUMAN CELL; POLYGONUM CUSPIDATUM; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

HEPATITIS B VIRUS; POLYGONUM CUSPIDATUM;

EID: 15244361219     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2004.12.006     Document Type: Article

References (40)

1. D.O. Andersen, N.D. Weber, S.G. Wood, B.G. Hughes, B.K. Murray, and J.A. North In vitro virucidal activity of selected anthraquinones and anthraquinone derivatives Antiviral Res. 16 1991 185 196
2. E.A. Ayoola, M.S. Balayab, F. Deinhardt, I. Gust, A.W. Kureshi, and J.E. Maynard Bull. World Health Organ. 66 1988 443 455
3. S. Banerjee, C. Bueso-Ramos, and B.B. Aggarwal Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9 Cancer Res. 62 2002 4945 4954
4. D.L. Barnard, J.H. Huffman, J.L. Morris, S.G. Wood, B.G. Hughes, and R.W. Sidwell Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus Antiviral Res. 17 1992 63 77
5. R.P. Beasley, L.Y. Hwang, C.C. Lin, and C.S. Chien Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22707 men in Taiwan Lancet 21 8256 1981 1129 1133
6. Y. Benhamou, M. Bochet, V. Thibault, V. Di Martino, E. Caumes, F. Bricaire, P. Opolon, C. Katlama, and T. Poynard Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients Hepatology 30 1999 1302 1306
7. V. Carreno, P. Marcellin, S. Hadziyannis, J. Salmeron, M. Diago, G.E. Kitis, I. Vafiadis, S.W. Schalm, F. Zahm, F. Manzarbeitia, F.J. Jimenez, and J.A. Quiroga Retreatment of chronic hepatitis B e antigen-positive patients with recombinant interferon alfa-2a. The European Concerted Action on Viral Hepatitis (EUROHEP) Hepatology 30 1999 277 282
8. R.W. Chen, H. Piiparinen, M. Seppanen, P. Koskela, S. Sarna, and M. Lappalainen Real-time PCR for detection and quantitation of hepatitis B virus DNA J. Med. Virol. 65 2001 250 256
9. F. Chisari, and C. Ferrari Hepatitis B virus immunopathogenesis Annu. Rev. Immunol. 13 1995 29 60
10. P.A. Cohen, J.B. Hudson, and G.H. Towers Antiviral activities of anthraquinones, bianthrones and hypericin derivatives from lichens Experientia 52 1996 180 183
11. J.L. Dienstag, and K.J. Isselbacher Chronic hepatitis E. Braunwald A.S. Fauci D.L. Kasper S.L. Hauser D.L. Longo J.L. Jameson Harrison's Principle of Internal Medicine 2001 McGraw-Hill 1742 1752
12. J.L. Dienstag, and K.J. Isselbacher Acute viral hepatitis E. Braunwald A.S. Fauci D.L. Kasper S.L. Hauser D.L. Longo J.L. Jameson Harrison's Principle of Internal Medicine 2001 McGraw-Hill 1721 1737
13. J.L. Dienstag, E.R. Schiff, T.L. Wright, R.P. Perrillo, H.W. Hann, Z. Goodman, L. Crowther, L.D. Condreay, M. Woessner, M. Rubin, and N.A. Brown Lamivudine as initial treatment for chronic hepatitis B in the United States N. Engl. J. Med. 341 1999 1256 1263
14. S.L. Doong, C.H. Tsai, R.F. Schinazi, D.C. Liotta, and Y.C. Cheng Inhibition of the replication of hepatitis B virus in vitro by 2′,3′-dideoxy-3′-thiacytidine and related analogues Proc. Natl. Acad. Sci. U.S.A. 88 1991 8495 8499
15. L.G. Guidotti, R. Rochford, J. Chung, M. Shapiro, R. Purcell, and F.V. Chisari Viral clearance without destruction of infected cells during acute HBV infection Science 284 1999 825 829
16. F.B. Hollinger, and T.J. Liang Hepatitis B virus B.N. Fields D.M. Knipe P.M. Howley Fields Virology 1996 Lippincott-Raven Philadelphia 2971 3036
17. J.H. Hoofnagle, and A.M. Di Bisceglie The treatment of chronic viral hepatitis N. Engl. J. Med. 336 1997 347 356
18. S.F. Innaimo, M. Seifer, G.S. Bisacchi, D.N. Standring, R. Zahler, and R.J. Colonno Identification of BMS-200475 as a potent and selective inhibitor of hepatitis B virus Antimicrob. Agents Chemother. 41 1997 1444 1448
19. H. Jayasuriya, N.M. Koonchanok, R.L. Geahlen, J.L. McLaughlin, and C.J. Chang Emodin, a protein tyrosine kinase inhibitor from Polygonum cuspidatum J. Nat. Prod. 55 1992 696 698
20. G.S. Jayatilake, H. Jayasuriya, E.S. Lee, N.M. Koonchanok, R.L. Geahlen, C.L. Ashendel, J.L. McLaughlin, and C.J. Chang Kinase inhibitors from Polygonum cuspidatum J. Nat. Prod. 56 1993 1805 1810
21. Y. Kimura, and H. Okuda Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice J. Nutr. 131 2001 1844 1849
22. C.L. Lai, R.N. Chien, N.W. Leung, T.T. Chang, R. Guan, D.I. Tai, K.Y. Ng, P.C. Wu, J.C. Dent, J. Barber, S.L. Stephenson, and D.F. Gray A one-year trial of lamivudine for chronic hepatitis B N. Engl. J. Med. 339 1998 61 68
23. N.W. Leung, C.L. Lai, T.T. Chang, R. Guan, C.M. Lee, K.Y. Ng, S.G. Lim, P.C. Wu, J.C. Dent, S. Edmundson, L.D. Condreay, R.N. Chien On behalf of the Asia Hepatitis Lamivudine Study Group Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: results after 3 years of therapy Hepatology 33 2001 1527 1532
24. Y.F. Liaw, D.I. Tai, C.M. Chu, and T.J. Chen The development of cirrhosis in patients with chronic type B hepatitis: a prospective study Hepatology 8 1988 493 496
25. Y.F. Liaw, N.W. Leung, T.T. Chang, R. Guan, D.I. Tai, K.Y. Ng, R.N. Chien, J. Dent, L. Roman, S. Edmundson, and C.L. Lai Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B Gastroenterology 119 2000 172 180
26. R. Ling, D. Mutimer, M. Ahmed, E.H. Boxall, E. Elias, G.M. Dusheiko, and T.J. Harrison Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine Hepatology 24 1996 711 713
27. F.J. Mahoney Update on diagnosis, management, and prevention of hepatitis B virus infection Clin. Microbiol. Rev. 12 1999 351 366
28. E.K. Manesis, and S.J. Hadziyannis Interferon a treatment and retreatment of hepatitis B e antigen-negative chronic hepatitis B Gastroenterology 121 2001 101 109
29. B.J. McMahon, S.R. Alberts, R.B. Wainwright, L. Bulkow, and A.P. Lanier Hepatitis B-related sequelae: prospective study in 1400 hepatitis B surface antigen-positive Alaska native carriers Arch. Intern. Med. 150 1990 1051 1054
30. C. Niederau, T. Heintges, S. Lange, G. Goldmann, C.M. Niederau, L. Mohr, and D. Haussinger Long-term follow-up of HBeAg positive patients treated with interferon alfa for chronic hepatitis B N. Engl. J. Med. 334 1996 1422 1427
31. M. Rapicetta, C. Ferrari, and M. Levrero Viral determinants and host immune responses in the pathogenesis of HBV infection J. Med. Virol. 67 2002 454 457
32. M.A. Sells, M.L. Chen, and G. Acs Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA Proc. Natl. Acad. Sci. U.S.A. 84 1987 1005 1009
33. R.J. Sydiskis, D.G. Owen, J.L. Lohr, K.H. Rosler, and R.N. Blomster Inactivation of enveloped viruses by anthraquinones extracted from plants Antimicrob. Agents Chemother. 35 1991 2463 2466
34. N.C. Tassopoulos, R. Volpes, G. Pastore, J. Heathcote, M. Buti, R.D. Goldin, S. Hawley, J. Barber, L. Condreay, and D.F. Gray Efficacy of lamivudine in patients with hepatitis B e antigen-negative/hepatitis B virus DNA-positive (precore mutant) chronic hepatitis B Hepatology 29 1999 889 896
35. G.A. Tipples, M.M. Ma, K.P. Fischer, V.G. Bain, N.M. Kneteman, and D.L. Tyrrell Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo Hepatology 24 1996 714 717
36. G.J. Webster, S. Reignat, M.K. Maini, S.A. Whalley, G.S. Ogg, A. King, D. Brown, P.L. Amlot, R. Williams, D. Vergani, G.M. Dusheiko, and A. Bertoletti Incubation phase of acute hepatitis B in man: dynamic of cellular immune mechanisms Hepatology 32 2000 1117 1124
37. S.F. Wieland, L.G. Guidotti, and F.V. Chisari Intrahepatic induction of alpha/beta interferon eliminates viral RNA-containing capsids in hepatitis B virus transgenic mice J. Virol. 74 2000 4165 4173
38. D.K.H. Wong, A.M. Cheung, K. O'Rourke, C. David Naylor, A.S. Detsky, and J. Heathcote Effect of alpha-interferon treatment in patients with hepatitis B e antigen positive chronic hepatitis B. A meta-analysis Ann. Intern. Med. 119 1993 312 323
39. M.H. Yen, C.C. Lin, C.H. Chuang, and S.Y. Liu Evaluation of root quality of Bupleurum species by TLC scanner and the liver protective effects of "xiao-chai-hu-tang" prepared using three different Bupleurum species J. Ethnopharmacol. 34 1991 155 165
40. Zheng, H.Z., Dong, Z.H., She, J. (Eds.), 1998. Huzhang, Rhizoma polygoni cuspidati. In: Modern Study of Traditional Chinese Medicine, Xue Yuan Press, Beijing, vol. 3, 2800-2820.